If you have or previously had any of these health conditions, you should immediately consult your provider to see if Semaglutide is right for you
Personalized Assessment and Support We offer a free assessment quiz to help determine eligibility for prescription weight loss medications, including Semaglutide and Tirzepatide
Understanding the distinction between FDA-approved dosing and experimental microdosing strategies is essential for safe, effective treatment
PE-22-28 Safety Considerations# PE-22-28's safety profile is less burdened by mechanism-specific concerns: TREK-1 channels are expressed throughout the body (brain, heart, vasculature, gastrointestinal tract), so systemic TREK-1 blockade could theoretically affect cardiovascular function, pain sensation, and gastrointestinal motility
Both medications have their roles in obesity management, and the choice between the two will often fall on individual patient needs, preferences, medical history, and a healthcare providers recommendation